Ondansetron Hydrochloride Solution
Product Images NDC 55154-4453

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 55154-4453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (992e78b1 Bd2c 4e54 8a3f 425e8aea8542 01)

Chemical structure of Ondansetron Hydrochloride, showing the molecular arrangement including a fused bicyclic ring system linked to a methylated nitrogen-containing heterocycle, accompanied by hydrochloride and dihydrate indicated as HCl·2H2O.*

FDA Label Image

Ceb5cebe 9feb 4009 Aa71 5c1fa88104ce 00

Ondansetron Injection USP 4 mg/2 mL (2 mg/mL) solution for intravenous or intramuscular injection. The label states this package contains 5 single-use vials of 2 mL each. Manufactured by Baxter Pharmaceuticals India and distributed by Cardinal Health 107, LLC. The label includes storage instructions, warnings, and dosage form information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.